Ali J. Satvat - Net Worth and Insider Trading
Ali J. Satvat Net Worth
The estimated net worth of Ali J. Satvat is at least $3.0 Billion dollars as of 2024-04-28. Ali J. Satvat is the Director, 10% Owner of Eidos Therapeutics Inc and owns about 24,575,501 shares of Eidos Therapeutics Inc (EIDX) stock worth over $3.0 Billion. Details can be seen in Ali J. Satvat's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ali J. Satvat has not made any transactions after 2019-07-03 and currently still holds the listed stock(s).
Transaction Summary of Ali J. Satvat
Ali J. Satvat Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ali J. Satvat owns 4 companies in total, including BridgeBio Pharma Inc (BBIO) , Eidos Therapeutics Inc (EIDX) , and Coherus BioSciences Inc (CHRS) among others .
Click here to see the complete history of Ali J. Satvat’s form 4 insider trades.
Insider Ownership Summary of Ali J. Satvat
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BBIO | BridgeBio Pharma Inc | 2019-06-27 | director |
| EIDX | Eidos Therapeutics Inc | 2020-05-27 | director & 10 percent owner |
| CHRS | Coherus BioSciences Inc | 2016-05-24 | director |
| IMPLQ | IPI Legacy Liquidation Co | 2021-04-22 | director |
Ali J. Satvat Latest Holdings Summary
Ali J. Satvat currently owns a total of 1 stock. Ali J. Satvat owns 24,575,501 shares of Eidos Therapeutics Inc (EIDX) as of July 3, 2019, with a value of $3.0 Billion.
Latest Holdings of Ali J. Satvat
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EIDX | Eidos Therapeutics Inc | 2019-07-03 | 24,575,501 | 122.21 | 3,003,371,977 |
Holding Weightings of Ali J. Satvat
Ali J. Satvat Form 4 Trading Tracker
According to the SEC Form 4 filings, Ali J. Satvat has made a total of 2 transactions in Eidos Therapeutics Inc (EIDX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Eidos Therapeutics Inc is the acquisition of 882,353 shares on July 3, 2019, which cost Ali J. Satvat around $26 Million.
Insider Trading History of Ali J. Satvat
- 1
Ali J. Satvat Trading Performance
GuruFocus tracks the stock performance after each of Ali J. Satvat's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ali J. Satvat is 1.71%. GuruFocus also compares Ali J. Satvat's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ali J. Satvat within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ali J. Satvat's insider trading performs compared to the benchmark.
Performance of Ali J. Satvat
Average Return
37.07%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -7.03 | 1.71 | 34.92 | 37.07 | 49.91 | |
| Relative Return to S&P 500(%) | -8.3 | 0.3 | 33 | 31.68 | 43.53 |
Ali J. Satvat Ownership Network
Ownership Network List of Ali J. Satvat
Ownership Network Relation of Ali J. Satvat
Ali J. Satvat Owned Company Details
What does BridgeBio Pharma Inc do?
Who are the key executives at BridgeBio Pharma Inc?
Ali J. Satvat is the director of BridgeBio Pharma Inc. Other key executives at BridgeBio Pharma Inc include Chairman of Oncology Frank Mccormick , director & See Remarks Neil Kumar , and See Remarks Brian C Stephenson .
BridgeBio Pharma Inc (BBIO) Insider Trades Summary
Over the past 18 months, Ali J. Satvat made no insider transaction in BridgeBio Pharma Inc (BBIO). Other recent insider transactions involving BridgeBio Pharma Inc (BBIO) include a net sale of 1,034,094 shares made by Neil Kumar , a net sale of 412,388 shares made by Brian C Stephenson , and a net sale of 9,500 shares made by Randal W Scott .
In summary, during the past 3 months, insiders sold 2,500 shares of BridgeBio Pharma Inc (BBIO) in total and bought 0 shares, with a net sale of 2,500 shares. During the past 18 months, 3,064,727 shares of BridgeBio Pharma Inc (BBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,064,727 shares.
BridgeBio Pharma Inc (BBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
BridgeBio Pharma Inc Insider Transactions
Ali J. Satvat Mailing Address
Above is the net worth, insider trading, and ownership report for Ali J. Satvat. You might contact Ali J. Satvat via mailing address: C/o Kohlberg Kravis Roberts & Co., 2800 Sand Hill Road, Suite 200, Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
